Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of SunTrap.

    Client Virtual Booth

    SUNTRAP

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    SunTrap
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    24th FloorBlock 12th Avenue, Gaur City-2, GH-03, Sector-16C, Greater Noida
    Telephone
    Telephone
    +91 95402 63987
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://suntrap.in/about-us-2/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Suntrap Discovered 'LeSoleil' for COVID-19 and the Epidemic

    Details:

    LeSoleil' series of drugs can block the broad-spectrum coronavirus infection, resist further development of respiratory infection and kill the viruses.


    Lead Product(s): LeSoleil

    Therapeutic Area: Infections and Infectious Diseases Product Name: LeSoleil

    Highest Development Status: PreclinicalProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable February 14, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Suntrap Life Technologies Discovers Natural anti-COVID-19 Compound

    Details:

    LeSoleil', a naturally active compound, was discovered as a therapeutic candidate for use against COVID-19. Results from a study conducted by Suntrap Life Technologies indicated 'LeSoleil' has a potent in vitro inhibitory effect on COVID-19.


    Lead Product(s): LeSoleil

    Therapeutic Area: Infections and Infectious Diseases Product Name: LeSoleil

    Highest Development Status: PreclinicalProduct Type: Undisclosed

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable December 24, 2020

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search